1-4 of 4
Emily Curran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Dose Escalation Study of Dual PI3K and DNA PK Inhibitor, BR101801 in Adult Patients with Advanced Hematologic Malignancies

Tae Min Kim, Dok Hyun Yoon, Ahmad H. Mattour, Jorge M. Chaves, Emily Curran, Yoon Kyung Jeon, Bong-Seog Kim, Seok Jin Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3562.
https://doi.org/10.1182/blood-2021-149927
Published: 2021
Journal Articles

Taking a “BiTE out of ALL”: blinatumomab approval for MRD-positive ALL

Clinical Trials & Observations
Emily Curran, Wendy Stock
Journal: Blood
Blood (2019) 133 (16): 1715–1719.
https://doi.org/10.1182/blood-2018-12-852376
Published: 2019
Journal Articles

How I treat acute lymphoblastic leukemia in older adolescents and young adults

Clinical Trials & Observations
Emily Curran, Wendy Stock
Journal: Blood
Blood (2015) 125 (24): 3702–3710.
https://doi.org/10.1182/blood-2014-11-551481
Published: 2015
Journal Articles

Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).

Olatoyosi Odenike, Emily Curran, Neil Iyengar, Leslie Popplewell, Mark Kirschbaum, Harry P Erba, Margaret Green, Xavier Poiré, Pamela Ihonor, Ernesto Diaz-Flores, Kevin Shannon, Ehab Atallah, James L Wade, III, Maria Perdekamp, Sreenivasa Nattam, Sachdev P. Thomas, Scott E. Smith, L. Austin Doyle, Elizabeth Shima Rich, Richard A. Larson, Wendy Stock
Journal: Blood
Blood (2009) 114 (22): 2081.
https://doi.org/10.1182/blood.V114.22.2081.2081
Published: 2009